REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

PAVICS ES TARSAI Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: PAVICS ES TARSAI Bt. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

PAVICS ES TARSAI Bt. is an enterprise based in Hungary. Its main office is in Veszprem. It operates in the Pharmacies and Drug Stores industry. The company was established on December 19, 1994. 6 (2024) employees currently work for PAVICS ES TARSAI Bt.. In 2024, the company reported a net sales revenue increase of 9.93%. Its’ total assets recorded a growth of 11.23%. PAVICS ES TARSAI Bt.’s net profit margin increased by 0.27% in 2024.

Headquarters
Narcisz u. 7/A.
Veszprem; Veszprem; Postal Code: 8200

Contact Details: Purchase the PAVICS ES TARSAI Bt. report to view the information.

Website: http://www.feherurom.hu

Basic Information
Total Employees:
Purchase the PAVICS ES TARSAI Bt. report to view the information.
Registered Capital:
Purchase the PAVICS ES TARSAI Bt. report to view the information.
Financial Auditors:
Purchase the PAVICS ES TARSAI Bt. report to view the information.
Incorporation Date:
December 19, 1994
Key Executives
Purchase this report to view the information.
Executive Officer
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Magyar Gyogyszer Zrt .
Company Performance
Financial values in the chart are available after PAVICS ES TARSAI Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
9.93%▲
Total operating revenue
10.35%▲
Operating profit (EBIT)
32.13%▲
EBITDA
31.62%▲
Net Profit (Loss) for the Period
14.09%▲
Total Assets
11.23%▲
Total Equity
11.82%▲
Operating Profit Margin (ROS)
1.25%▲
Net Profit Margin
0.27%▲
Return on Equity (ROE)
0.75%▲
Quick Ratio
-0.38%▼
Cash Ratio
-0.39%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo